XML 85 R49.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Deferred Policy Acquisition Costs, Value of Business Acquired, Unearned Revenue and Other Intangibles (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract] |
Schedule of Deferred Policy Acquisition Costs and Value of Business Acquired | Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:
| Group Benefits |  | RIS |  | Asia (1) |  | Latin America (2) |  | EMEA (2) |  | MetLife Holdings (3) |  | Corporate & Other |  | Total
| (In millions)
DAC: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at January 1, 2022 | $ | 272 |  |  | $ | 191 |  |  | $ | 10,058 |  |  | $ | 1,361 |  |  | $ | 1,472 |  |  | $ | 4,029 |  |  | $ | 32 |  |  | $ | 17,415 |
Capitalizations | 18 |  |  | 113 |  |  | 1,530 |  |  | 494 |  |  | 422 |  |  | 29 |  |  | 8 |  |  | 2,614 |
Amortization | (26) |  |  | (37) |  |  | (644) |  |  | (361) |  |  | (311) |  |  | (267) |  |  | (9) |  |  | (1,655) |
Effect of foreign currency translation and other, net | — |  |  | — |  |  | (674) |  |  | 48 |  |  | (103) |  |  | — |  |  | (1) |  |  | (730) |
Balance at December 31, 2022 | 264 |  |  | 267 |  |  | 10,270 |  |  | 1,542 |  |  | 1,480 |  |  | 3,791 |  |  | 30 |  |  | 17,644 |
Capitalizations | 20 |  |  | 176 |  |  | 1,583 |  |  | 651 |  |  | 457 |  |  | 22 |  |  | 8 |  |  | 2,917 |
Amortization | (26) |  |  | (46) |  |  | (705) |  |  | (418) |  |  | (332) |  |  | (255) |  |  | (9) |  |  | (1,791) |
Effect of foreign currency translation and other, net (4) | — |  |  | — |  |  | (284) |  |  | 175 |  |  | 13 |  |  | (287) |  |  | 1 |  |  | (382) |
Balance at December 31, 2023 | 258 |  |  | 397 |  |  | 10,864 |  |  | 1,950 |  |  | 1,618 |  |  | 3,271 |  |  | 30 |  |  | 18,388 |
Capitalizations | 18 |  |  | 218 |  |  | 1,380 |  |  | 704 |  |  | 486 |  |  | 17 |  |  | 10 |  |  | 2,833 |
Amortization | (26) |  |  | (63) |  |  | (782) |  |  | (461) |  |  | (345) |  |  | (225) |  |  | (10) |  |  | (1,912) |
Effect of foreign currency translation and other, net | — |  |  | — |  |  | (677) |  |  | (357) |  |  | (95) |  |  | — |  |  | (2) |  |  | (1,131) |
Balance at December, 31, 2024 | $ | 250 |  |  | $ | 552 |  |  | $ | 10,785 |  |  | $ | 1,836 |  |  | $ | 1,664 |  |  | $ | 3,063 |  |  | $ | 28 |  |  | $ | 18,178 |
VOBA: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at January 1, 2022 | $ | — |  |  | $ | 22 |  |  | $ | 1,593 |  |  | $ | 591 |  |  | $ | 154 |  |  | $ | 31 |  |  | $ | — |  |  | $ | 2,391 |
Amortization | — |  |  | (3) |  |  | (101) |  |  | (49) |  |  | (20) |  |  | (3) |  |  | — |  |  | (176) |
Effect of foreign currency translation and other, net | — |  |  | — |  |  | (202) |  |  | 3 |  |  | (7) |  |  | — |  |  | — |  |  | (206) |
Balance at December 31, 2022 | — |  |  | 19 |  |  | 1,290 |  |  | 545 |  |  | 127 |  |  | 28 |  |  | — |  |  | 2,009 |
Amortization | — |  |  | (3) |  |  | (89) |  |  | (50) |  |  | (16) |  |  | (3) |  |  | — |  |  | (161) |
Effect of foreign currency translation and other, net (4) | — |  |  | — |  |  | (82) |  |  | 2 |  |  | 2 |  |  | (7) |  |  | — |  |  | (85) |
Balance at December 31, 2023 | — |  |  | 16 |  |  | 1,119 |  |  | 497 |  |  | 113 |  |  | 18 |  |  | — |  |  | 1,763 |
Amortization | — |  |  | (3) |  |  | (71) |  |  | (42) |  |  | (14) |  |  | (4) |  |  | — |  |  | (134) |
Effect of foreign currency translation and other, net | — |  |  | — |  |  | (113) |  |  | (62) |  |  | (5) |  |  | — |  |  | — |  |  | (180) |
Balance at December 31, 2024 | $ | — |  |  | $ | 13 |  |  | $ | 935 |  |  | $ | 393 |  |  | $ | 94 |  |  | $ | 14 |  |  | $ | — |  |  | $ | 1,449 |
Total DAC and VOBA: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at December 31, 2022 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 19,653 |
Balance at December 31, 2023 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 20,151 |
Balance at December 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 19,627 |
__________________ (1)Includes DAC balances primarily related to accident & health, universal and variable universal life, variable life and fixed annuity products and VOBA balances primarily related to accident & health products. (2)Includes DAC balances primarily related to universal life, variable universal life, ordinary life and accident & health productsIncludes DAC balances primarily related to whole life, variable annuities, term life, universal life, variable universal life and long-term care products. (4)MetLife Holdings segment includes activity for total DAC and total VOBA ceded at the date of inception related to a reinsurance agreement. See Note 9 for further information on the transaction.
Deferred Policy Acquisition Costs | Information regarding total DAC and VOBA by segment, as well as Corporate & Other, was as follows at:
| Group Benefits |  | RIS |  | Asia (1) |  | Latin America (2) |  | EMEA (2) |  | MetLife Holdings (3) |  | Corporate & Other |  | Total
| (In millions)
DAC: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at January 1, 2022 | $ | 272 |  |  | $ | 191 |  |  | $ | 10,058 |  |  | $ | 1,361 |  |  | $ | 1,472 |  |  | $ | 4,029 |  |  | $ | 32 |  |  | $ | 17,415 |
Capitalizations | 18 |  |  | 113 |  |  | 1,530 |  |  | 494 |  |  | 422 |  |  | 29 |  |  | 8 |  |  | 2,614 |
Amortization | (26) |  |  | (37) |  |  | (644) |  |  | (361) |  |  | (311) |  |  | (267) |  |  | (9) |  |  | (1,655) |
Effect of foreign currency translation and other, net | — |  |  | — |  |  | (674) |  |  | 48 |  |  | (103) |  |  | — |  |  | (1) |  |  | (730) |
Balance at December 31, 2022 | 264 |  |  | 267 |  |  | 10,270 |  |  | 1,542 |  |  | 1,480 |  |  | 3,791 |  |  | 30 |  |  | 17,644 |
Capitalizations | 20 |  |  | 176 |  |  | 1,583 |  |  | 651 |  |  | 457 |  |  | 22 |  |  | 8 |  |  | 2,917 |
Amortization | (26) |  |  | (46) |  |  | (705) |  |  | (418) |  |  | (332) |  |  | (255) |  |  | (9) |  |  | (1,791) |
Effect of foreign currency translation and other, net (4) | — |  |  | — |  |  | (284) |  |  | 175 |  |  | 13 |  |  | (287) |  |  | 1 |  |  | (382) |
Balance at December 31, 2023 | 258 |  |  | 397 |  |  | 10,864 |  |  | 1,950 |  |  | 1,618 |  |  | 3,271 |  |  | 30 |  |  | 18,388 |
Capitalizations | 18 |  |  | 218 |  |  | 1,380 |  |  | 704 |  |  | 486 |  |  | 17 |  |  | 10 |  |  | 2,833 |
Amortization | (26) |  |  | (63) |  |  | (782) |  |  | (461) |  |  | (345) |  |  | (225) |  |  | (10) |  |  | (1,912) |
Effect of foreign currency translation and other, net | — |  |  | — |  |  | (677) |  |  | (357) |  |  | (95) |  |  | — |  |  | (2) |  |  | (1,131) |
Balance at December, 31, 2024 | $ | 250 |  |  | $ | 552 |  |  | $ | 10,785 |  |  | $ | 1,836 |  |  | $ | 1,664 |  |  | $ | 3,063 |  |  | $ | 28 |  |  | $ | 18,178 |
VOBA: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at January 1, 2022 | $ | — |  |  | $ | 22 |  |  | $ | 1,593 |  |  | $ | 591 |  |  | $ | 154 |  |  | $ | 31 |  |  | $ | — |  |  | $ | 2,391 |
Amortization | — |  |  | (3) |  |  | (101) |  |  | (49) |  |  | (20) |  |  | (3) |  |  | — |  |  | (176) |
Effect of foreign currency translation and other, net | — |  |  | — |  |  | (202) |  |  | 3 |  |  | (7) |  |  | — |  |  | — |  |  | (206) |
Balance at December 31, 2022 | — |  |  | 19 |  |  | 1,290 |  |  | 545 |  |  | 127 |  |  | 28 |  |  | — |  |  | 2,009 |
Amortization | — |  |  | (3) |  |  | (89) |  |  | (50) |  |  | (16) |  |  | (3) |  |  | — |  |  | (161) |
Effect of foreign currency translation and other, net (4) | — |  |  | — |  |  | (82) |  |  | 2 |  |  | 2 |  |  | (7) |  |  | — |  |  | (85) |
Balance at December 31, 2023 | — |  |  | 16 |  |  | 1,119 |  |  | 497 |  |  | 113 |  |  | 18 |  |  | — |  |  | 1,763 |
Amortization | — |  |  | (3) |  |  | (71) |  |  | (42) |  |  | (14) |  |  | (4) |  |  | — |  |  | (134) |
Effect of foreign currency translation and other, net | — |  |  | — |  |  | (113) |  |  | (62) |  |  | (5) |  |  | — |  |  | — |  |  | (180) |
Balance at December 31, 2024 | $ | — |  |  | $ | 13 |  |  | $ | 935 |  |  | $ | 393 |  |  | $ | 94 |  |  | $ | 14 |  |  | $ | — |  |  | $ | 1,449 |
Total DAC and VOBA: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at December 31, 2022 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 19,653 |
Balance at December 31, 2023 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 20,151 |
Balance at December 31, 2024 |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 19,627 |
__________________ (1)Includes DAC balances primarily related to accident & health, universal and variable universal life, variable life and fixed annuity products and VOBA balances primarily related to accident & health products. (2)Includes DAC balances primarily related to universal life, variable universal life, ordinary life and accident & health productsIncludes DAC balances primarily related to whole life, variable annuities, term life, universal life, variable universal life and long-term care products. (4)MetLife Holdings segment includes activity for total DAC and total VOBA ceded at the date of inception related to a reinsurance agreement. See Note 9 for further information on the transaction.
Value of Distribution Agreements and Customer Relationships Acquired and Negative Value of Business Acquired | Information regarding other intangibles was as follows:
|  | Years Ended December 31,
|  | 2024 |  | 2023 |  | 2022
|  | (In millions)
VODA and VOCRA: |  |  |  |  |  |
Balance at January 1, |  | $ | 794 |  |  | $ | 876 |  |  | $ | 972 |
Amortization |  | (85) |  |  | (88) |  |  | (92) |
Effect of foreign currency translation and other |  | 1 |  |  | 6 |  |  | (4) |
Balance at December 31, |  | $ | 710 |  |  | $ | 794 |  |  | $ | 876 |
Accumulated amortization |  | $ | 840 |  |  | $ | 755 |  |  | $ | 667 |
Negative VOBA: |  |  |  |  |  |
Balance at January 1, |  | $ | 427 |  |  | $ | 473 |  |  | $ | 557 |
Amortization |  | (25) |  |  | (26) |  |  | (29) |
Effect of foreign currency translation and other |  | (33) |  |  | (20) |  |  | (55) |
Balance at December 31, |  | $ | 369 |  |  | $ | 427 |  |  | $ | 473 |
Accumulated amortization |  | $ | 3,423 |  |  | $ | 3,398 |  |  | $ | 3,372 |
Estimated Future Amortization Expense (Credit) | The estimated future amortization expense (credit) to be reported in other expenses for the next five years is as follows:
|  | VOBA |  | VODA and VOCRA |  | Negative VOBA
|  | (In millions)
2025 |  | $ | 116 |  |  | $ | 81 |  |  | $ | (24) |
2026 |  | $ | 109 |  |  | $ | 80 |  |  | $ | (23) |
2027 |  | $ | 101 |  |  | $ | 78 |  |  | $ | (21) |
2028 |  | $ | 93 |  |  | $ | 75 |  |  | $ | (20) |
2029 |  | $ | 87 |  |  | $ | 73 |  |  | $ | (19) |
Unearned Revenue | Information regarding the Company’s UREV primarily related to universal life and variable universal life products by segment included in other policy-related balances was as follows:
|  | RIS |  | Asia |  | Latin America |  | EMEA |  | MetLife Holdings |  | Total
|  | (In millions)
Balance at January 1, 2022 |  | $ | 38 |  |  | $ | 2,033 |  |  | $ | 795 |  |  | $ | 521 |  |  | $ | 238 |  |  | $ | 3,625 |
Deferrals |  | 5 |  |  | 546 |  |  | 134 |  |  | 111 |  |  | 60 |  |  | 856 |
Amortization |  | (7) |  |  | (144) |  |  | (116) |  |  | (59) |  |  | (17) |  |  | (343) |
Effect of foreign currency translation and other - net |  | — |  |  | (53) |  |  | 35 |  |  | (14) |  |  | — |  |  | (32) |
Balance at December 31, 2022 |  | 36 |  |  | 2,382 |  |  | 848 |  |  | 559 |  |  | 281 |  |  | 4,106 |
Deferrals |  | 2 |  |  | 667 |  |  | 147 |  |  | 95 |  |  | 48 |  |  | 959 |
Amortization |  | (7) |  |  | (181) |  |  | (116) |  |  | (63) |  |  | (18) |  |  | (385) |
Effect of foreign currency translation and other - net (1) |  | — |  |  | (18) |  |  | 110 |  |  | 17 |  |  | (252) |  |  | (143) |
Balance at December 31, 2023 |  | 31 |  |  | 2,850 |  |  | 989 |  |  | 608 |  |  | 59 |  |  | 4,537 |
Deferrals |  | 2 |  |  | 534 |  |  | 146 |  |  | 98 |  |  | 15 |  |  | 795 |
Amortization |  | (6) |  |  | (228) |  |  | (115) |  |  | (68) |  |  | (5) |  |  | (422) |
Effect of foreign currency translation and other - net |  | — |  |  | (80) |  |  | (179) |  |  | (16) |  |  | — |  |  | (275) |
Balance at December 31, 2024 |  | $ | 27 |  |  | $ | 3,076 |  |  | $ | 841 |  |  | $ | 622 |  |  | $ | 69 |  |  | $ | 4,635 |
__________________ (1)MetLife Holdings segment includes activity for total UREV ceded at the date of inception related to a reinsurance agreement. See Note 9 for further information on the transaction.

X
- Definition Tabular disclosure of the estimated aggregate amortization expense (credit) for intangible assets (liabilities) subject to amortization for each of the five succeeding fiscal years. + References No definition available. + Details
Name: | met_ScheduleOfExpectedAmortizationExpenseCreditTableTextBlock
Namespace Prefix: | met_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment and amount of negative value of business acquired costs amortized for each period presented and the unamortized balance as of each balance sheet date. + References No definition available. + Details
Name: | met_ScheduleofFiniteLivedIntangibleAssetsandNegativeValueofBusinessAcquiredTableTextBlock
Namespace Prefix: | met_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquiredAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the movement in deferred policy acquisition costs. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479432/944-30-50-2B Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479432/944-30-50-2B Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 944 -SubTopic 30 -Name Accounting Standards Codification -Section 55 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479401/944-30-55-2 + Details
Name: | us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the type of arrangements and the corresponding amounts that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date. + References No definition available. + Details
Name: | us-gaap_DeferredRevenueByArrangementDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of present value of future profits of insurance contract acquired in business combination. + References No definition available. + Details
Name: | us-gaap_PresentValueOfFutureInsuranceProfitsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration